CIAM
CGEM icon

Caitong International Asset Management’s Cullinan Oncology CGEM Stock Holding History

Caitong International Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74K Buy
+315
New +$4.68K ﹤0.01% 1270
2026
Q1 		– Sell
-4,680
Closed -$48.4K – 2662
2025
Q4 		$48.4K Buy
4,680
+3,020
+182% +$27.2K 0.01% 712
2025
Q3 		$9.84K Buy
1,660
+547
+49% +$4.01K 0.01% 1024
2025
Q2 		$8.38K Buy
1,113
+712
+178% +$5.72K 0.01% 794
2025
Q1 		$3.04K Buy
+401
New +$3.85K ﹤0.01% 1183

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Caitong International Asset Management's CGEM Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 315 shares worth $5.74K. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CGEM as recently as Q4 2025.

Caitong International Asset Management first reported a position in CGEM in Q1 2025 and has held it in 5 quarters since. The position peaked at $48.4K in Q4 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Caitong International Asset Management held 315 shares of Cullinan Oncology worth $5.74K as of Q2 2026.
  • Cullinan Oncology was a new Caitong International Asset Management position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1270 holding.
  • Caitong International Asset Management first reported a position in Cullinan Oncology in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Cullinan Oncology position peaked at $48.4K in Q4 2025.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.